DCM
UTMD icon

Dupont Capital Management’s Utah Medical Products UTMD Stock Holding History

Dupont Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,357
Closed -$417K – 1279
2019
Q2 		$417K Buy
+4,357
New +$367K 0.01% 861

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dupont Capital Management's UTMD Position: Q3 2019 in Review

Dupont Capital Management sold out of Utah Medical Products (UTMD) in Q3 2019, closing a stake of 4,357 shares — an estimated $417K sold.

Dupont Capital Management first reported a position in UTMD in Q2 2019 and held it in 1 quarter. The position peaked at $417K in Q2 2019. 97 funds tracked by Wall St. Rank hold UTMD as of Q3 2019.

  • Dupont Capital Management reported no remaining Utah Medical Products position as of Q3 2019 after selling out during the quarter.
  • Dupont Capital Management sold 4,357 Utah Medical Products shares in Q3 2019, an estimated $417K.
  • Dupont Capital Management first reported a position in Utah Medical Products in Q2 2019 and held it in 1 quarter.
  • Dupont Capital Management's Utah Medical Products position peaked at $417K in Q2 2019.
  • 97 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2019.

Based on Dupont Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.